Canna Law Blog

SEPTEMBER 25, 2023

Cannabis rescheduling appears to be a matter of time and my colleagues have written about the possible implications (see here , here , and here ). Rescheduling to a less restrictive category will also have implications for trademarking by cannabis brands. Cannabis rescheduling would change that.

DEA 99

DEA Food Cannabis Hemp 99

The Blunt Truth

OCTOBER 29, 2020

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. New York releases new CBD regulations, and Governor Cuomo supports legal cannabis. The Montana Supreme Court denied a ballot initiative challenge, and some in the medical marijuana industry oppose the measure.

DEA 116

DEA Hemp Extraction Food 116

Marijuana Lawyer Blog

JANUARY 12, 2019

Department of Justice, challenging the constitutionality of the federal law designating marijuana a Schedule I controlled substance proceeded recently to the next level with oral arguments before the U.S. Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government.

DEA 40

DEA Patients Epilepsy Medicine 40

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference.

DEA 45

DEA Law Policy Safety 45

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Medical Marijuana Program Connection

FEBRUARY 20, 2024

The Food and Drug Administration recently offered a glimpse into its comprehensive analysis justifying its recommendation to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act.

Media 53

Media Data Marijuana Food 53

United Patients Group

JANUARY 15, 2023

As the legality of hemp and cannabis products strengthens, people are curious to learn more about the different compounds they contain. CBD and THC are two natural substances found in the cannabis plant. CBD is derived from hemp or marijuana plants, both species of Cannabis Sativa. Defining CBD and THC.

THC 114

THC CBD DEA Cannabinoids 114

NORML

JANUARY 15, 2020

Members of the House Energy and Commerce Subcommittee on Health today held a legislative hearing, “ Cannabis Policies for the New Decade ,” during which they considered multiple legislative bills aimed at amending federal cannabis laws. He continued: “The fact of the matter is that legalization and regulation work.

Policy 192

Policy DEA Legislation Data 192

Canna Law Blog

SEPTEMBER 25, 2023

Cannabis rescheduling appears to be a matter of time and my colleagues have written about the possible implications (see here , here , and here ). Rescheduling to a less restrictive category will also have implications for trademarking by cannabis brands. Cannabis rescheduling would change that.

DEA 52

DEA Food Cannabis Hemp 52

Canna Law Blog

JULY 26, 2023

Last week, a LinkedIn post by cannabis economist Beau Whitney caught my eye, because Beau said something pretty amazing. Many of them are in the legally problematic CBD food and beverage space. And here’s the fundamental problem, in my opinion: hemp and marijuana are the same plant, albeit with different levels of THC.

Hemp 81

Hemp DEA THC Policy 81

TheAnswerPage

JULY 31, 2022

The “Cannabis Administration and Opportunity Act (CAOA) Series” continues: If cannabis is legalized at the federal level, the federal jurisdiction over cannabis would be impacted. Describe some of the proposed changes in federal oversight that deal with the Drug Enforcement Agency (DEA). See the Answer.

DEA 52

DEA Food Patients Legalization 52

Canna Law Blog

AUGUST 16, 2022

If you’re a cannabis lab, researcher, or scientist, the NIH is interested in hearing your thoughts! Last week, the National Institute of Health (NIH) posted a request for information (RFI)* regarding identifying the barriers to cannabis research. What barriers prevent cannabis research?

DEA 66

DEA Access Cannabinoids Cannabis 66

Cannabis Law Report

JULY 6, 2021

The category that’s generated the most interest is cannabinoid-infused dietary supplements and food items – primarily CBD products marketed for a variety of health purposes. The FDA has jurisdiction over the area and hasn’t developed rules allowing for CBD products in the food supply. Marijuana Moment. Marijuana Moment.

Hemp 105

Hemp CBD DEA Legalization 105

FloridaMarijuana.net

JULY 8, 2018

5 cannabis strains to treat PTSD? Medical marijuana can contribute to a patient’s overall health. Cannabis offers significant therapeutic benefits for a wide range of medical conditions. Food and Drug Administration. The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs).

Strains 190

Strains Indica Hybrid Research and Development 190

Veriheal

APRIL 30, 2021

The city of Denver finally approves social smoking lounges and delivery to help open up the cannabis industry. Nebraska officialized a political party dedicated to obliterating cannabis prohibition, and congress officials request that the US Botanical Garden in Washington D.C. Denver Approves Cannabis Smoking Lounges and More.

Hemp 96

Hemp DEA Cannabis Agriculture 96

Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Drug Enforcement Agency (DEA).

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. Despite the widespread adoption, the Food and Drug Administration still classifies cannabis as a Schedule One drug. Simply put, in the eyes of federal law, cannabis is illegal. Is Medical Cannabis Legal? No, they can’t.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

JUNE 16, 2019

Marijuana Moment reports. They cover everything from preventing the Justice Department from interfering in state legal marijuana programs to funding the creation of a regulatory pathway for CBD to be introduced into the food supply to shifting Drug Enforcement Administration (DEA) funds to substance abuse prevention and education programs.

DEA 58

DEA Education Programs Food 58

Cannabis Law Report

JULY 30, 2021

On July 14, 2021, Senators Chuck Schumer (D-NY), Ron Wyden (D-OR), and Cory Booker (D-NJ) released the discussion draft of historic federal cannabis legalization legislation, the Cannabis Administration and Opportunity Act (CAOA). Food and Drug Administration (FDA) and the Alcohol and Tobacco Tax and Trade Bureau (TTB).

Hemp 105

Hemp Law Seed-To-Sale Food 105

The Blunt Truth

OCTOBER 15, 2019

Medical Marijuana, Inc., We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% of THC (tetrahydrocannabinols) are now considered Schedule V drugs provided they are approved by the federal Food and Drug Administration (FDA).

THC 87

THC CBD DEA Policy 87

SpeedWeed

MARCH 11, 2021

Back in August 2020, the Drug Enforcement Administration (the “DEA”) released its Interim Final Rule (the “ IFR” ) in which the agency stated, in part, that “[a]ll synthetically derived tetrahydrocannabinols remain schedule I controlled substances.” Emphasis added).

THC 52

THC Business DEA Cannabinoids 52

Canna Law Blog

MAY 24, 2022

” Specifically, “the only statutory metric for distinguishing controlled marijuana from legal hemp is the delta-9 THC concentration level.” This includes all products derived from marijuana. Trademark Act (also known as the Lanham Act).

Legalization 77

Legalization DEA THC Hemp 77

The Blunt Truth

DECEMBER 29, 2023

Welcome back to The Year In Weed, The Blunt Truth’s annual roundup of cannabis-related stories. Last year , I predicted there would be no federal cannabis legalization, but that perhaps states would legalize. Virgin Islands legalized adult-use cannabis. March brought an election defeat for adult-use cannabis.

DEA 52

DEA Retail Legalization Food 52

Canna Law Blog

JULY 17, 2020

I want to study marijuana (cannabis), peyote, MDMA, psilocybin, LSD, ayahuasca/DMT and ibogaine, to start. Q: OK, I want to study cannabis. Q: What’s so hard about cannabis? A: Most cannabis research applications are ignored, or swatted away after being ignored and litigated and ignored some more.

DEA 85

DEA Research and Development Therapy Banking 85

The Blunt Truth

MAY 7, 2020

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. On the federal level, there’s some support for cannabis to be part of the next stimulus bill. And there’s an issue with marijuana research. We’re starting out this week with state news. State news.

DEA 101

DEA Dispensary Legislation Programs 101

The Blunt Truth

MARCH 5, 2020

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. Lawmakers wrestled with the issue of capping THC content in medical marijuana for those patients under the age of 21. In Vermont , legislation to establish a marijuana marketplace passed on a second reading in the House.

Banking 99

Banking DEA THC Hemp 99

Cannabis Law Report

AUGUST 5, 2019

This week I moderated a webinar at the Food & Drug Law Institute (FDLI) on the regulation of cannabis-derived products. In the federal executive branch alone, DOJ (especially DEA), USDA, FDA, and NIH all play major roles. This is a product & policy area that’s evolving as I type.

DEA 55

DEA Food Treatment CBD 55

Cannabis Chronicles

MARCH 29, 2019

But now, a few months after Congress placed the marijuana look-alike squarely in safe legal territory, the hemp industry has been unsettled by an unexpected development. Marijuana, illegal under federal law , has enough THC to get users high. The pure CBD powder is then resold for use in everything from makeup to smoothies to pet food.

Hemp 186

Hemp Legalization Agriculture Pets 186

Cannabis Law Report

AUGUST 12, 2022

Marijuana Moment report on some of the panels being proposed for 2023…… Voting is now open for the public to decide which panels will make the stage at next year’s South By Southwest (SXSW) festival—and there are about 100 marijuana- and psychedelics-related proposals to pick from. Is cannabis actually. Green or not?

Research and Development 52

Research and Development Events Topical Policy 52

Cannabis Law Report

JULY 28, 2022

Colorado was the first state in 2012 to legalize the recreational use of marijuana, also through a voter initiative. Schedule I drugs include substances that are not recognized for medical use and that the Drug Enforcement Administration (DEA) defines as having a high potential for abuse and dependence. Blog: Food Safety News.

Legalization 52

Legalization Decriminalization Food Safety 52

Cannabis Law Report

JULY 20, 2021

GEO), a leading manufacturer and distributor of premium certified organic soils and nutrients specifically designed to optimize the purity and yield of cannabis and hemp cultivation, will close its Regulation A+ crowdfunding raise this Friday, July 23, 2021 at 11:59 pm. .–(BUSINESS WIRE)–The Good Earth Organics, Inc.

DEA 98

DEA Cultivation Access Hemp 98

Cannabis Law Report

AUGUST 12, 2022

In ruling that delta-8 THC is legal for purposes of trademark protection, the Ninth Circuit opined that products containing delta-8 THC are generally legal because they are hemp derived products and federal law defines hemp as “any part of” the cannabis plant, including “all derivatives, extracts, [and] cannabinoids,” containing less than 0.3%

THC 52

THC DEA Hemp Vaping 52

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] DEA and the Controlled Substances Act. Stacy Cline Amin. Times (Nov.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

United Patients Group

FEBRUARY 21, 2023

Understanding the 4 Major Differences Between CBD and THC CBD and THC are both compounds that can be found in the Cannabis plant. THC CBD is derived from the Cannabis sativa plant, with hemp and cannabis being the primary sources. Legality In the United States, cannabis laws are changing rapidly. percent or less.

THC 52

THC CBD Patients DEA 52

Cannabis Law Report

NOVEMBER 18, 2021

Attorney General, Merrick Garland, initiate proceedings under the Controlled Substances Act (CSA) to deschedule cannabis. This would, as the letter to Garland says, “decriminalize” marijuana. Currently, the CSA classifies cannabis as a Schedule I substance, alongside substances like heroin and ecstasy. The CSA’s Power.

Decriminalization 52

Decriminalization DEA Cannabis Business 52

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. Therefore, it no longer meets the criteria for placement in Schedule I. While … Keep reading.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

Cannabis Law Report

JULY 7, 2019

RE-PUBLISHED BY : CANNABIS LAW REPORT. Notwithstanding, this re-branding and imaging of cannabis, the basis for much of this confusion is the Controlled Substances Act. As a refresher, cannabis is classified as a “Schedule I” substance, which, defines it as a substance with no currently accepted medical use. De Ingeniis.

DEA 40

DEA Pharmaceutical Conditions Patients 40